recombinant protein dimer Search Results


90
R&D Systems recombinant protein dimer
Enhanced ILT4-mediated binding of the HLA-B2705–KK10 L6M complex to peripheral blood macrophages and DCs. (A) Histograms indicating the binding of the HLA-B2705–KK10 WT or KK10 L6M pentamers to macrophages, DCs, lymphocytes, or KK10-specific CD8 T cell clones in the presence or absence of ILT4-blocking antibodies. (B) Mean fluorescence intensity of the respective pentamers after gating on CD14 + macrophages or CD11c + lin − HLA-DR + DCs. Data from 10 HLA-B2705 − chronically HIV-1–infected, treatment-naive subjects are shown. (C) Mean fluorescence intensity of the B2705–KK10 WT and L6M variant pentamers after staining with the indicated pentamer dilutions (x axis) on CD14 + macrophages. (D) SPR sensograms reflecting the control surface–subtracted interactions between immobilized HLA-B27–KK10 L6M (top) and B27–KK10 WT (bottom) with <t>recombinant</t> ILT4. ILT4 was injected in five serial twofold dilutions from a starting concentration of 74 μg/ml (1 μM). Inset plots show nonlinear regression analysis of maximal responses versus concentration. One representative experiment out of three is shown.
Recombinant Protein Dimer, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+protein+dimer/Recombinant+Human+IL-26%2FAK155+Dimer+Protein%2C+CF/pmc02118510-162-14-32
Average 90 stars, based on 1 article reviews
recombinant protein dimer - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

92
R&D Systems recombinant human il 26 dimer protein
Enhanced ILT4-mediated binding of the HLA-B2705–KK10 L6M complex to peripheral blood macrophages and DCs. (A) Histograms indicating the binding of the HLA-B2705–KK10 WT or KK10 L6M pentamers to macrophages, DCs, lymphocytes, or KK10-specific CD8 T cell clones in the presence or absence of ILT4-blocking antibodies. (B) Mean fluorescence intensity of the respective pentamers after gating on CD14 + macrophages or CD11c + lin − HLA-DR + DCs. Data from 10 HLA-B2705 − chronically HIV-1–infected, treatment-naive subjects are shown. (C) Mean fluorescence intensity of the B2705–KK10 WT and L6M variant pentamers after staining with the indicated pentamer dilutions (x axis) on CD14 + macrophages. (D) SPR sensograms reflecting the control surface–subtracted interactions between immobilized HLA-B27–KK10 L6M (top) and B27–KK10 WT (bottom) with <t>recombinant</t> ILT4. ILT4 was injected in five serial twofold dilutions from a starting concentration of 74 μg/ml (1 μM). Inset plots show nonlinear regression analysis of maximal responses versus concentration. One representative experiment out of three is shown.
Recombinant Human Il 26 Dimer Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+protein+dimer/Recombinant+Human+IL-26%2FAK155+Dimer+Protein/pm37234157-55-29-42
Average 92 stars, based on 1 article reviews
recombinant human il 26 dimer protein - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier

94
R&D Systems recombinant human il 26 rhil 26
Enhanced ILT4-mediated binding of the HLA-B2705–KK10 L6M complex to peripheral blood macrophages and DCs. (A) Histograms indicating the binding of the HLA-B2705–KK10 WT or KK10 L6M pentamers to macrophages, DCs, lymphocytes, or KK10-specific CD8 T cell clones in the presence or absence of ILT4-blocking antibodies. (B) Mean fluorescence intensity of the respective pentamers after gating on CD14 + macrophages or CD11c + lin − HLA-DR + DCs. Data from 10 HLA-B2705 − chronically HIV-1–infected, treatment-naive subjects are shown. (C) Mean fluorescence intensity of the B2705–KK10 WT and L6M variant pentamers after staining with the indicated pentamer dilutions (x axis) on CD14 + macrophages. (D) SPR sensograms reflecting the control surface–subtracted interactions between immobilized HLA-B27–KK10 L6M (top) and B27–KK10 WT (bottom) with <t>recombinant</t> ILT4. ILT4 was injected in five serial twofold dilutions from a starting concentration of 74 μg/ml (1 μM). Inset plots show nonlinear regression analysis of maximal responses versus concentration. One representative experiment out of three is shown.
Recombinant Human Il 26 Rhil 26, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+protein+dimer/Recombinant+Human+IL-26%2FAK155+Dimer+Protein/pmc07415539-61-0-8
Average 94 stars, based on 1 article reviews
recombinant human il 26 rhil 26 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

90
Becton Dickinson dimer x recombinant soluble dimeric mouse h2-ld:ig fusion protein
Enhanced ILT4-mediated binding of the HLA-B2705–KK10 L6M complex to peripheral blood macrophages and DCs. (A) Histograms indicating the binding of the HLA-B2705–KK10 WT or KK10 L6M pentamers to macrophages, DCs, lymphocytes, or KK10-specific CD8 T cell clones in the presence or absence of ILT4-blocking antibodies. (B) Mean fluorescence intensity of the respective pentamers after gating on CD14 + macrophages or CD11c + lin − HLA-DR + DCs. Data from 10 HLA-B2705 − chronically HIV-1–infected, treatment-naive subjects are shown. (C) Mean fluorescence intensity of the B2705–KK10 WT and L6M variant pentamers after staining with the indicated pentamer dilutions (x axis) on CD14 + macrophages. (D) SPR sensograms reflecting the control surface–subtracted interactions between immobilized HLA-B27–KK10 L6M (top) and B27–KK10 WT (bottom) with <t>recombinant</t> ILT4. ILT4 was injected in five serial twofold dilutions from a starting concentration of 74 μg/ml (1 μM). Inset plots show nonlinear regression analysis of maximal responses versus concentration. One representative experiment out of three is shown.
Dimer X Recombinant Soluble Dimeric Mouse H2 Ld:Ig Fusion Protein, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+protein+dimer/dimer+x+recombinant+soluble+dimeric+mouse+h2+ld+ig+fusion+protein/pm15723299-67-4-13
Average 90 stars, based on 1 article reviews
dimer x recombinant soluble dimeric mouse h2-ld:ig fusion protein - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Becton Dickinson recombinant cd1/β2m dimer proteins
Enhanced ILT4-mediated binding of the HLA-B2705–KK10 L6M complex to peripheral blood macrophages and DCs. (A) Histograms indicating the binding of the HLA-B2705–KK10 WT or KK10 L6M pentamers to macrophages, DCs, lymphocytes, or KK10-specific CD8 T cell clones in the presence or absence of ILT4-blocking antibodies. (B) Mean fluorescence intensity of the respective pentamers after gating on CD14 + macrophages or CD11c + lin − HLA-DR + DCs. Data from 10 HLA-B2705 − chronically HIV-1–infected, treatment-naive subjects are shown. (C) Mean fluorescence intensity of the B2705–KK10 WT and L6M variant pentamers after staining with the indicated pentamer dilutions (x axis) on CD14 + macrophages. (D) SPR sensograms reflecting the control surface–subtracted interactions between immobilized HLA-B27–KK10 L6M (top) and B27–KK10 WT (bottom) with <t>recombinant</t> ILT4. ILT4 was injected in five serial twofold dilutions from a starting concentration of 74 μg/ml (1 μM). Inset plots show nonlinear regression analysis of maximal responses versus concentration. One representative experiment out of three is shown.
Recombinant Cd1/β2m Dimer Proteins, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+protein+dimer/recombinant+cd1+%CE%B22m+dimer+proteins/us09657046-914-5-9
Average 90 stars, based on 1 article reviews
recombinant cd1/β2m dimer proteins - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Becton Dickinson recombinant soluble dimeric h-2ld:ig fusion protein
Enhanced ILT4-mediated binding of the HLA-B2705–KK10 L6M complex to peripheral blood macrophages and DCs. (A) Histograms indicating the binding of the HLA-B2705–KK10 WT or KK10 L6M pentamers to macrophages, DCs, lymphocytes, or KK10-specific CD8 T cell clones in the presence or absence of ILT4-blocking antibodies. (B) Mean fluorescence intensity of the respective pentamers after gating on CD14 + macrophages or CD11c + lin − HLA-DR + DCs. Data from 10 HLA-B2705 − chronically HIV-1–infected, treatment-naive subjects are shown. (C) Mean fluorescence intensity of the B2705–KK10 WT and L6M variant pentamers after staining with the indicated pentamer dilutions (x axis) on CD14 + macrophages. (D) SPR sensograms reflecting the control surface–subtracted interactions between immobilized HLA-B27–KK10 L6M (top) and B27–KK10 WT (bottom) with <t>recombinant</t> ILT4. ILT4 was injected in five serial twofold dilutions from a starting concentration of 74 μg/ml (1 μM). Inset plots show nonlinear regression analysis of maximal responses versus concentration. One representative experiment out of three is shown.
Recombinant Soluble Dimeric H 2ld:Ig Fusion Protein, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+protein+dimer/recombinant+soluble+dimeric+h+2ld+ig+fusion+protein/pm16935945-69-9-14
Average 90 stars, based on 1 article reviews
recombinant soluble dimeric h-2ld:ig fusion protein - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Levena Biopharma chemicals, peptides, and recombinant proteins pbd dimer
Enhanced ILT4-mediated binding of the HLA-B2705–KK10 L6M complex to peripheral blood macrophages and DCs. (A) Histograms indicating the binding of the HLA-B2705–KK10 WT or KK10 L6M pentamers to macrophages, DCs, lymphocytes, or KK10-specific CD8 T cell clones in the presence or absence of ILT4-blocking antibodies. (B) Mean fluorescence intensity of the respective pentamers after gating on CD14 + macrophages or CD11c + lin − HLA-DR + DCs. Data from 10 HLA-B2705 − chronically HIV-1–infected, treatment-naive subjects are shown. (C) Mean fluorescence intensity of the B2705–KK10 WT and L6M variant pentamers after staining with the indicated pentamer dilutions (x axis) on CD14 + macrophages. (D) SPR sensograms reflecting the control surface–subtracted interactions between immobilized HLA-B27–KK10 L6M (top) and B27–KK10 WT (bottom) with <t>recombinant</t> ILT4. ILT4 was injected in five serial twofold dilutions from a starting concentration of 74 μg/ml (1 μM). Inset plots show nonlinear regression analysis of maximal responses versus concentration. One representative experiment out of three is shown.
Chemicals, Peptides, And Recombinant Proteins Pbd Dimer, supplied by Levena Biopharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+protein+dimer/chemicals++peptides++and+recombinant+proteins+pbd+dimer/pmc08324494__mmc2-427-62-68
Average 90 stars, based on 1 article reviews
chemicals, peptides, and recombinant proteins pbd dimer - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Becton Dickinson recombinant soluble dimeric h-2 ld:ig fusion protein
Enhanced ILT4-mediated binding of the HLA-B2705–KK10 L6M complex to peripheral blood macrophages and DCs. (A) Histograms indicating the binding of the HLA-B2705–KK10 WT or KK10 L6M pentamers to macrophages, DCs, lymphocytes, or KK10-specific CD8 T cell clones in the presence or absence of ILT4-blocking antibodies. (B) Mean fluorescence intensity of the respective pentamers after gating on CD14 + macrophages or CD11c + lin − HLA-DR + DCs. Data from 10 HLA-B2705 − chronically HIV-1–infected, treatment-naive subjects are shown. (C) Mean fluorescence intensity of the B2705–KK10 WT and L6M variant pentamers after staining with the indicated pentamer dilutions (x axis) on CD14 + macrophages. (D) SPR sensograms reflecting the control surface–subtracted interactions between immobilized HLA-B27–KK10 L6M (top) and B27–KK10 WT (bottom) with <t>recombinant</t> ILT4. ILT4 was injected in five serial twofold dilutions from a starting concentration of 74 μg/ml (1 μM). Inset plots show nonlinear regression analysis of maximal responses versus concentration. One representative experiment out of three is shown.
Recombinant Soluble Dimeric H 2 Ld:Ig Fusion Protein, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+protein+dimer/recombinant+soluble+dimeric+h+2+ld+ig+fusion+protein/pmc00385409-322-20-26
Average 90 stars, based on 1 article reviews
recombinant soluble dimeric h-2 ld:ig fusion protein - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Becton Dickinson h-2k b –ig recombinant fusion protein (dimerx
Enhanced ILT4-mediated binding of the HLA-B2705–KK10 L6M complex to peripheral blood macrophages and DCs. (A) Histograms indicating the binding of the HLA-B2705–KK10 WT or KK10 L6M pentamers to macrophages, DCs, lymphocytes, or KK10-specific CD8 T cell clones in the presence or absence of ILT4-blocking antibodies. (B) Mean fluorescence intensity of the respective pentamers after gating on CD14 + macrophages or CD11c + lin − HLA-DR + DCs. Data from 10 HLA-B2705 − chronically HIV-1–infected, treatment-naive subjects are shown. (C) Mean fluorescence intensity of the B2705–KK10 WT and L6M variant pentamers after staining with the indicated pentamer dilutions (x axis) on CD14 + macrophages. (D) SPR sensograms reflecting the control surface–subtracted interactions between immobilized HLA-B27–KK10 L6M (top) and B27–KK10 WT (bottom) with <t>recombinant</t> ILT4. ILT4 was injected in five serial twofold dilutions from a starting concentration of 74 μg/ml (1 μM). Inset plots show nonlinear regression analysis of maximal responses versus concentration. One representative experiment out of three is shown.
H 2k B –Ig Recombinant Fusion Protein (Dimerx, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+protein+dimer/h+2k+b++ig+recombinant+fusion+protein++dimer+x/pmc03209401-81-40-47
Average 90 stars, based on 1 article reviews
h-2k b –ig recombinant fusion protein (dimerx - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Becton Dickinson recombinant soluble dimeric mouse h-2l d :ig (dimerx) protein
Sensorgram graph <t>of</t> <t>H-2L</t> d :Ig <t>DimerX</t> protein immobilization on a carboxylated surface sensor chip. Protein immobilization graphs are observed on channels 1 (dark blue) and 3 (dark red). The stabilized dissociation RU values were considered as baseline for posterior studies of DimerX interaction with synthetic peptides. The data are representative of two replicates.
Recombinant Soluble Dimeric Mouse H 2l D :Ig (Dimerx) Protein, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+protein+dimer/recombinant+soluble+dimeric+mouse+h+2l+d++ig++dimerx++protein/pmc05361054-32-6-30
Average 90 stars, based on 1 article reviews
recombinant soluble dimeric mouse h-2l d :ig (dimerx) protein - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Becton Dickinson phycoerythrinconjugated recombinant soluble dimeric h-2d/ig fusion protein
Sensorgram graph <t>of</t> <t>H-2L</t> d :Ig <t>DimerX</t> protein immobilization on a carboxylated surface sensor chip. Protein immobilization graphs are observed on channels 1 (dark blue) and 3 (dark red). The stabilized dissociation RU values were considered as baseline for posterior studies of DimerX interaction with synthetic peptides. The data are representative of two replicates.
Phycoerythrinconjugated Recombinant Soluble Dimeric H 2d/Ig Fusion Protein, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+protein+dimer/phycoerythrinconjugated+recombinant+soluble+dimeric+h+2d+ig+fusion+protein/pmc04734840__EMMM___8___155___s001-156-18-25
Average 90 stars, based on 1 article reviews
phycoerythrinconjugated recombinant soluble dimeric h-2d/ig fusion protein - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

93
Bio-Techne corporation recombinant mouse ephrin-a1 fc chimera protein, cf
Sensorgram graph <t>of</t> <t>H-2L</t> d :Ig <t>DimerX</t> protein immobilization on a carboxylated surface sensor chip. Protein immobilization graphs are observed on channels 1 (dark blue) and 3 (dark red). The stabilized dissociation RU values were considered as baseline for posterior studies of DimerX interaction with synthetic peptides. The data are representative of two replicates.
Recombinant Mouse Ephrin A1 Fc Chimera Protein, Cf, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+protein+dimer/Recombinant+Mouse+Ephrin-A1+Fc+Chimera+Protein%2C+CF/bio-techne+corporation___602-a1
Average 93 stars, based on 1 article reviews
recombinant mouse ephrin-a1 fc chimera protein, cf - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

Image Search Results


Enhanced ILT4-mediated binding of the HLA-B2705–KK10 L6M complex to peripheral blood macrophages and DCs. (A) Histograms indicating the binding of the HLA-B2705–KK10 WT or KK10 L6M pentamers to macrophages, DCs, lymphocytes, or KK10-specific CD8 T cell clones in the presence or absence of ILT4-blocking antibodies. (B) Mean fluorescence intensity of the respective pentamers after gating on CD14 + macrophages or CD11c + lin − HLA-DR + DCs. Data from 10 HLA-B2705 − chronically HIV-1–infected, treatment-naive subjects are shown. (C) Mean fluorescence intensity of the B2705–KK10 WT and L6M variant pentamers after staining with the indicated pentamer dilutions (x axis) on CD14 + macrophages. (D) SPR sensograms reflecting the control surface–subtracted interactions between immobilized HLA-B27–KK10 L6M (top) and B27–KK10 WT (bottom) with recombinant ILT4. ILT4 was injected in five serial twofold dilutions from a starting concentration of 74 μg/ml (1 μM). Inset plots show nonlinear regression analysis of maximal responses versus concentration. One representative experiment out of three is shown.

Journal: The Journal of Experimental Medicine

Article Title: A viral CTL escape mutation leading to immunoglobulin-like transcript 4–mediated functional inhibition of myelomonocytic cells

doi: 10.1084/jem.20061865

Figure Lengend Snippet: Enhanced ILT4-mediated binding of the HLA-B2705–KK10 L6M complex to peripheral blood macrophages and DCs. (A) Histograms indicating the binding of the HLA-B2705–KK10 WT or KK10 L6M pentamers to macrophages, DCs, lymphocytes, or KK10-specific CD8 T cell clones in the presence or absence of ILT4-blocking antibodies. (B) Mean fluorescence intensity of the respective pentamers after gating on CD14 + macrophages or CD11c + lin − HLA-DR + DCs. Data from 10 HLA-B2705 − chronically HIV-1–infected, treatment-naive subjects are shown. (C) Mean fluorescence intensity of the B2705–KK10 WT and L6M variant pentamers after staining with the indicated pentamer dilutions (x axis) on CD14 + macrophages. (D) SPR sensograms reflecting the control surface–subtracted interactions between immobilized HLA-B27–KK10 L6M (top) and B27–KK10 WT (bottom) with recombinant ILT4. ILT4 was injected in five serial twofold dilutions from a starting concentration of 74 μg/ml (1 μM). Inset plots show nonlinear regression analysis of maximal responses versus concentration. One representative experiment out of three is shown.

Article Snippet: Serial twofold dilutions (74 μg/ml [1 μM] to 4.6 μg/ml [62.5 nM]) of a recombinant protein dimer containing two extracellular domains of human ILT4 fused to the Fc part of human IgG (R&D Systems) were injected over the sensor chip.

Techniques: Binding Assay, Clone Assay, Blocking Assay, Fluorescence, Infection, Variant Assay, Staining, Control, Recombinant, Injection, Concentration Assay

Sensorgram graph of H-2L d :Ig DimerX protein immobilization on a carboxylated surface sensor chip. Protein immobilization graphs are observed on channels 1 (dark blue) and 3 (dark red). The stabilized dissociation RU values were considered as baseline for posterior studies of DimerX interaction with synthetic peptides. The data are representative of two replicates.

Journal: BioMed Research International

Article Title: Exploring the Association of Surface Plasmon Resonance with Recombinant MHC:Ig Hybrid Protein as a Tool for Detecting T Lymphocytes in Mice Infected with Leishmania (Leishmania) amazonensis

doi: 10.1155/2017/9089748

Figure Lengend Snippet: Sensorgram graph of H-2L d :Ig DimerX protein immobilization on a carboxylated surface sensor chip. Protein immobilization graphs are observed on channels 1 (dark blue) and 3 (dark red). The stabilized dissociation RU values were considered as baseline for posterior studies of DimerX interaction with synthetic peptides. The data are representative of two replicates.

Article Snippet: Recombinant Soluble Dimeric Mouse H-2L d :Ig (DimerX) protein and monoclonal antibodies conjugates [phycoerythrin-Cy-7 (PE-Cy7) Hamster anti-mouse CD3e, phycoerythrin (PE) Rat anti-mouse CD4, and fluorescein (FITC) Rat] were purchased from BD Biosciences (Becton, Dickinson and Company, Franklin Lakes, NJ, USA).

Techniques: